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DESCRIPTION OF PARTICIPATING STUDIES 
 
Alienor 
The Alienor (Antioxydants, Lipides Essentiels, Nutrition et maladies OculaiRes) Study is a population-
based prospective study aiming at assessing the associations of age-related eye diseases (age-
related macular degeneration (AMD), glaucoma, cataract, dry eye syndrome) with nutritional factors (in 
particular antioxidants, macular pigment and fatty acids), determined from plasma measurements and 
estimation of dietary intakes. It also takes into account other major determinants of eye diseases, 
including gene polymorphisms, environmental factors and vascular factors. The methods of this study 
have been published elsewhere.
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Subjects of the Alienor Study were recruited from an ongoing population-based study on the vascular 
risk factors for dementia, the Three-City (3C) Study.
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 The 3C Study included 9,294 subjects aged 65 
years or more from three French Cities (Bordeaux, Dijon and Montpellier), among whom 2,104 were 
recruited in Bordeaux. They were initially recruited in 1999-2001 and followed-up about every two 
years since. The Alienor Study consists of eye examinations, which are proposed to all participants of 
the 3C cohort in Bordeaux since the third follow-up (2006-2008). Among the 1,450 participants re-
examined between October 2006 and May 2008, 963 (66.4%) participated in the Alienor Study’s 
baseline eye examination. This research followed the tenets of the Declaration of Helsinki. Participants 
gave written consent for participation in the study. The design of this study has been approved by the 
Ethical Committee of Bordeaux (Comité de Protection des Personnes Sud-Ouest et Outre-Mer III) in 
May 2006. 
Eye examinations included, for each eye, a recording of ophthalmological history, measures of visual 
acuity (ETDRS charts, Light House Low Vision, New York, NY) and refraction (Speedy K, Luneau, 
France), two 45° non mydriatic color retinal photographs (one centered on the macula, the other 
centred on the optic disc) (TRC NW6S, Topcon, Japan), measures of intraocular pressure (non 
contact tonometer (KT 800, Kowa, Japan) and central corneal thickness (Pachpen, Accutome Inc., 
Malvern Pa, USA) and break-up time test. In addition, from 2009, examinations with spectral-domain 
optical coherence tomography (Spectralis, Heidelberg Engineering, Heidelberg, Germany) and 
ultrawide field imaging (Optos Panoramic 200C, Optos plc, United Kingdom) were performed. AMD, 
other retinal diseases and glaucoma were classified using international classifications.  
 
 
Coimbra Eye Study 
 This was a cross-sectional, population-based study, including two Portuguese populations aged ≥ 55 
years. A total population of 6,023 adults was recruited from two Portuguese primary health-care units 
in the central region of Portugal – one from a coastal town (n=3000) and another from an inland town 
(n=3023). Between August 2009 and April 2011, subjects were recruited from the primary health-care 
center of the coastal town (Mira) and between April 2012 and October 2013 from the health-care unit 
of the inland town (Lousã). Report 1 of the Coimbra Eye Study provided the first population-based 
data on prevalence of AMD in a Portuguese population (Mira) 
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. In our second report we included 
additional data on prevalence and risk factors for AMD in Portugal, comparing two geographic different 
populations. 
All participants underwent complete bilateral ophthalmological examination and two 35° non-
simultaneous stereoscopic color fundus photographs were taken from fields 1M (centered on the optic 
disc), 2 (centered on the macula) and 3M (temporal to the macula), using a digital mydriatic Topocon
® 
fundus camera (TRC-50EX; Topcon Corporation, Tokyo, Japan). Images were analyzed in a step-wise 
manner by a centralized reading centre (Coimbra Ophthalmology Reading Centre, CORC - AIBILI): 
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the general analysis, aiming to identify major retinal pathology and a differential analysis for AMD 
lesions.  
The main outcome measures consisted of age and gender adjusted prevalence of early and late of 
AMD. We also evaluated the potential risk factors that could explain AMD prevalence in our study 
population using logistic regression analysis. The International Classification and Grading System 
(ICGS) for ARM and AMD was the chosen classification 
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 and the signs of disease were stratified into 
5 exclusive stages (ARM, stage 0 to 4) using the Rotterdam staging system 
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. This AMD grading was 
supported by a software to visualize digital colour fundus images and to grade retinal lesions – 
Retmarker AMD Research (Critical Health, SA, Portugal). 
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Socio-demographic and past medical history data were collected in the study visit by interview and 
included: date of birth; gender; relatives with history of AMD; smoking habits and alcohol consumption; 
diagnosis of hypertension, diabetes and cardiovascular diseases. Height and weight were obtained 
using standardized techniques and equipment, to enable the calculation of body mass index (Kg/m
2
). 
Demographic and clinical characterstics were summarized using descriptive methods. Categorical 
variables were reported by frequencies and percentages and numerical variables with mean and SD. 
T-tests and chi-squares were used to assess differences in age, gender, race, familiar history of AMD, 
smoking, body mass index, hypertension, diabetes and age of menopause between the two 
populations. ANOVA, t-tests and chi-squares were used to evaluate the independence of early, late 
and no AMD, according to the relevant clinical and demographic covariates. Age and gender-specific 
prevalences were calculated for early and late stages of AMD. Multinomial logistic regression analyses 
were performed to assess the univariate association of AMD with age, gender, smoking, body mass 
index, hypertension, diabetes, age of menopause, by estimating the odds ratios (OR), followed by 
multivariate analysis for association of AMD with all significant risk factors.  
 
Epic-Norfolk 
The European Prospective Investigation of Cancer (EPIC) is a 10 nation collaborative study which 
commenced in 1989. EPIC Norfolk enrolled 30,445men and women resident in the East Anglia region 
of England aged 40-79 years between 1993 – 97. The initial aim was to study dietary determinants of 
cancer, but the study was extended to identify other determinants of chronic disease. Visual health 
was included in the third health check (3HC) in which 8,623 people aged 48 – 92 years were 
examined. The cohort is 99.7% white.  Ocular data include ocular history, measures of logMAR visual 
acuity, auto-refraction and keratometry (Humphrey 500), intraocular pressure and corneal 
biomechanics (Reichert ORA), axial biometry (Zeiss IOLMaster), retinal nerve fibre layer thickness 
using a Zeiss GDx-VCC, optic nerve head topography (Heidelberg HRT II), and fundus photography 
using a Topcon TRC-NW5S + Nikon D80 non-mydriatic camera. Images have been graded for AMD, 
diabetic retinopathy and glaucoma. Visual field testing (Zeiss HFA2 750i running 24-2 SITA threshold 
programme) was attempted in all those with features suggesting an increased risk of glaucoma (IOP > 
24mmHg, abnormal GDx or HRT) and in 10% of those regarded as “normal”. Participants with 
abnormal features (VA > 0.34, IOP > 24mmHg, abnormal HRT or GDx, retinal abnormalities identified 
on photographs, visual field abnormalities, N = 1,703) were referred for examination by a senior 
ophthalmologist at the Norfolk and Norwich University Hospital.  Additional measures include height, 
weight, blood pressure, hip and waist measures, cognitive function and banked plasma, serum and 
urine. Genotyping on Affymetrix UK Biobank 820K SNP array has recently been completed on 3HC 
participants. Extensive questionnaire data have been collected using HLEQ and EPAQ2, and generic 
EPIC questionnaires recording socio-demographics & economic status, medication, smoking and 
alcohol, leisure activities and falls. Detailed 5 day diet diaries have been completed. Further 





The EUREYE Study is an epidemiological study funded by the European Commission Vth Framework 
(QLK6-CT-1999-02094). Additional funding was provided by the Macular Disease Society of the UK, 
Thomas Pocklington Trust and the UK Medical Research Council 
The main objectives of the EUREYE study are to (i) describe the prevalence  of  early and late age-
related macular degeneration(AMD)  in men and women aged 65 and over in the European setting (ii) 
to investigate the association of solar radiation with AMD (iii) to investigate the role of  dietary factors  
especially  antioxidants.  The EUREYE study was specifically designed to exploit the diversity of 
European populations in their exposures to these potential factors. The participating centres in the 
EUREYE study span a latitude of 22°, from 60° north to 38° south, a nearly 3-fold gradient of UVR. 
The EUREYE study is a multi-centre study in seven European countries following a common protocol. 
Participants (n=4753) were recruited from random sampling of the population aged over 65 years in 
the centres: Bergen (Norway), Tallinn (Estonia), Belfast (UK), Paris-Creteil (France), Verona (Italy), 
Thessaloniki (Greece), Alicante (Spain). Participants were interviewed by fieldworkers, underwent an 
ophthalmological examination including fundus photography and gave a blood sample for 
measurement of antioxidants and banking of DNA.  Information collected at interview included 
education, smoking and alcohol use, brief medical history, lifetime history of  residence, outdoor 
exposure and ocular protection, and a Food Frequency Questionnaire. AMD was assessed using 
digital Topcon fundus cameras (Topcon TRC-50EX, Topcon Corporation, Japan) and the settings 
were calibrated and standardised for all seven centres.  The fundus images were graded at a 
independent reading centre (Erasmus University Rotterdam) using the International Classification 
System for Age Related Maculopathy. 
 
Gutenberg Health Study 
The GHS is an ongoing, prospective, interdisciplinary, single-center, population-based cohort study in 
the Rhine-Main Region in midwestern Germany with a total of 15,010 participants and follow-up after 
five years
8 9
. The study sample is recruited from subjects aged between 35 and 74 years at the time of 
the exam. The sample was drawn randomly from local governmental registry offices and stratified by 
gender, residence (urban and rural) and decade of age. Exclusion criteria were insufficient knowledge 
of the German language to understand explanations and instructions, and physical or psychic inability 
to participate in the examinations in the study center. The main goals of the ophthalmological section 
are to assess the prevalence and incidence of ocular diseases and to explore risk factors, genetic 
determinants and associations with systemic diseases and conditions. The eye examination at 
baseline included a medical history, self-reported eye diseases, visual acuity, refractive errors, 
intraocular pressure, visual field, pachymetry, keratometry, fundus photography and tear sampling. 
The 5-year follow-up visit additionally encompassed optical coherence tomography, anterior segment 
imaging and optical biometry. The general examination included anthropometry; blood pressure 
measurement; carotid artery ultrasound; electrocardiogram; echocardiography; spirometry; cognitive 
tests; questionnaires; assessment of mental conditions; and DNA, RNA, blood and urine sampling. 
The GHS is the most extensive dataset of ophthalmic diseases and conditions and their risk factors in 
Germany and one of the largest cohorts worldwide. 
 
Montrachet 
Subjects of the MONTRACHET (Maculopathy Optic Nerve nuTRition neurovAsCular and HEarT 
diseases) study 
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 were recruited from an on going population-based study, the Three-City (3C) study, 
on the vascular risk factors for dementia 
11
. The 3C-Study was designed to examine the relationship 
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between vascular diseases and dementia in 9,294 community-dwelling persons aged 65 years and 
over. The participants were selected from the electoral rolls and were only urban since they lived in 3 
French cities, Bordeaux, Dijon and Montpellier. Eye examinations were proposed to 3C participants 
from 2009 in Dijon. 
In Dijon, 4931 subjects participated to the first run of the 3C-Study in 1999. At the fifth run, a subgroup 
of participants was invited to participate to the Montrachet study. Written informed consent was 
obtained. We chose preferentially the participants having had an MRI (n = 1663) and we completed 





, 2013, 900 volunteers with an MRI and 253 without an MRI were recruited in the 
Montrachet study. The participants of the Montrachet study represented 54.1% and 50.6% of the 
cohort still followed 10 years in Dijon after the initiation of the 3 C study, for those having had an MRI 
and those without MRI, respectively. 
The Montrachet study is a population-based study designed to find associations between age-related 
eye diseases and neurologic and heart diseases in the elderly as a primary objective. The secondary 
objective was to report the prevalence of the main age-related eye diseases in the elderly as well as 
the influence of genetic and environmental risk factors. Fasting blood samples were drawn. 
Technicians conducted the eye examination in the Department of Ophthalmology, University Hospital 
Dijon, France.  At the end of the eye examination participants were asked to fill at home a 
questionnaire about lifestyle, environment and nutrition (frequency food questionnaire). The following 
data were collected: ophthalmic history, visual acuity, refractive error, tonometry and pachymetry, slit-
lamp examination and ocular surface evaluation, visual field, OCT imaging, macular pigment 
assessment, two 45° non mydriatic color retinal photographs, one centred on the macula and one on 
the optic nerve head. AMD, other retinal diseases and glaucoma were classified using international 
classifications.  
 
MRC Older People Study 
The MRC Older People Study was a cluster randomised trial in general practice (family doctors) 
funded by the UK Medical Research Council and Departments of Health. The principal aim of the 
study was to evaluate different methods of health assessment and management of older people (aged 
75+). The two main arms of the study were Universal or targeted assessment.  Mortality, 2 year 
hospital admissions and nursing home admission and quality of life were the primary outcomes. A 
further aim of the study was to provide comprehensive data on the prevalence of health and social 
problems of older people and to investigate the relationship of these with health outcomes.  
All people aged 75 and over on the GP lists were eligible for the study provided they were not resident 
in a nursing home or hospital and were not terminally ill. The study commenced in 1995 and 106 
general practices (from the MRC General Practice Research Framework) and 33,000 patients aged 
over 75 years were recruited to the trial with response rates of 78%. In the Universal arm of the study, 
all participants (n=15,000) underwent an in-depth assessment by a study nurse, while in the Targeted 
arm, only participants with selected problems identified from a  brief health check (n=1500) went on to 
have the detailed assessment.  The detailed assessment included questionnaires: Mini-Mental State 
Examination for cognitive impairment, Geriatric Depression Scale, GHQ anxiety scale, Rose chest 
pain questionnaire for angina, MRC respiratory questionnaire, Activities of Daily Living, questions on 
incontinence and diabetes and a medical history including cardiovascular events. Lifestyle factors 
included current and past smoking behaviour, usual alcohol pattern and consumption of wine, beer 
and spirits and physical activity. Measurements included height, weight, mid upper arm circumference, 
demi span, waist and hip circumference, systolic and diastolic blood pressure, whispered voice test for 
hearing, Bailey Lovie Charts for visual acuity. Biological measurements included a urine dipstick for 
blood and protein, and a blood sample for a full biochemical screen.  In 49 practices, the cause of 
visual impairment was assessed by medical record review of ophthalmologists’ diagnosis. Over 50 
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papers have been published including the main trial 
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The PAMDI (Prevalence of Age-related Macular Degeneration in Italy) Study is population-based 
cross-sectional study aiming at estimating the prevalence, risk factors of age-related macular 
degeneration (AMD) and vision-related quality of life in an Italian population and to analyze differences 
between urban and rural communities. The methods of this study have been published elsewhere. 
Subjects aged 61 years or older were recruited from two communities in Northeast Italy: one living in 
an urban district of the city of Padua with a total of 2,495 inhabitants aged 61 years or older 
(representing 23.4% of the local population), and the other consisting of two municipalities in a rural 
area of Padua province, with a total of 3,189 inhabitants aged 61 or older (representing 21.8% of the 
local population). The two communities were representative of the general Italian population. The 
study was approved by the IRB of the University of Padua and performed in accordance with the 
Declaration of Helsinki. 
The sample size calculated from the target population consisted of 885 subjects. After giving written 
informed consent, two questionnaires were self-administered: i) NEI 25-itemVisual Function 
Questionnaire and ii) Food Frequency Questionnaire. All subjects were also interviewed about past 
medical history, demographic features and life-style habits (e.g. smoking habit, alcohol consumption 
and sunlight exposure). Participants underwent a complete ophthalmological assessment, including 
30°color fundus photographs of the posterior retina according to standard methods (ETDRS field 1M). 
The digital photographs were anonymized and sent to the Reading Centre (Moorfields Eye Hospital 
NHS Foundation Trust, London, UK) for grading. Raman Spectroscopy for measurement of 
xanthophyll pigments was also performed. Two papers have been published, regarding the 
epidemiologic results of the main study
13





The Pathologies Oculaires Liées à l’Age (POLA) Study is a population-based study aimed at 
identifying the risk factors of age-related eye diseases. The methods of this study have been published 
elsewhere.
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 For inclusion in the study, participants needed to be a resident of Sète (South of France) 
and aged 60 years and over. According to the 1990 population census, there were almost 12,000 
eligible residents, of whom our objective was to recruit 3,000. The population was informed of the 
study through the local media. We also contacted 4,543 residents individually by mail and telephone, 
using the electoral roll. The baseline examinations took place in a mobile unit equipped with 
ophthalmologic devices. Between June 1995 and July 1997, 2,584 participants were recruited. This 
research followed the tenets of the Declaration of Helsinki. Participants gave written consent for 
participation in the study. The study was approved by the ethics committee of the University Hospital 
of Montpellier, France. A follow-up examination was performed in 1998-2000, in 1, 947 of the 2,436 
survivors (79.9 %).  
Eye examinations included, for each eye, a recording of ophthalmological history, measures of visual 
acuity and refraction, one 50° mydriatic color retinal photograph centered on the macula, assessment 
of lens opacities at slit lamp using LOCSIII and measures of intraocular pressure. AMD was graded 





Rotterdam Study I/II/III 
The Rotterdam Studies are prospective cohort studies of people living in Ommoord, a district of the 
city of Rotterdam. This study investigates occurrence and risk factors of ophthalmic, cardiovascular, 
hepatic, neurological, psychiatric, dermatologic, oncological, respiratory and endocrine diseases in an 
elderly population. 
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 The ophthalmic part of the Rotterdam Study focusses on age-related macular 
degeneration, open angle glaucoma and myopia. In addition to risk analyses, potential biomarkers in 
various biosamples are investigated. 
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The Rotterdam Study consists of three cohorts of which the first started in 1990 and consisted of 7983 
participants of 55 years and older (RS I, response rate of 78%). The second cohort started recruiting in 
2000 and 3011 participants of 55 years and older were included (RS II, response rate of 67.3%). The 
third cohort also included people aged 45 years and older and consisted of 3932 participants (RS III, 
response rate 64.9%) starting from the year 2006. Follow-up of these cohorts took place about every 
3-5 years. Participants underwent an extensive physical examination at a research center. The study 
was approved by the institutional review board (Medical Ethics Committee)  of the Erasmus Medical 
Center and by the review board of the Netherlands Ministry of Health, Welfare and Sports, and 
participants gave written consent.  
The eye examinations consisted of medical ophthalmic history, presenting and best corrected visual 
acuity, refractive error, intra ocular pressure, axial length, biometry, perimetry, and in depth imaging 
such as mydriatic color fundus photography (one centered on the macula 35° and one on the optic 
nerve head 20°), HRA, HRT and OCT.  
Thessaloniki Eye Study 
The Thessaloniki Eye Study (TES), 2000-2005, is a cross-sectional, population-based, epidemiologic 
study of chronic eye diseases in the Greek population of Thessaloniki which is considered 
representative of the general population in the country. The initial recruitment frame consisted of 5,000 
people 60 years of age or older, identified randomly from approximately 321,000 persons registered in 
the municipality registers. 
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 From the initial recruitment sample, 3,617 subjects were eligible and 




The study was approved by the 
Aristotle University Hospital Ethics Committee and the University of California Los Angeles Human 
Subject Protection Committee. All study procedures adhered to the principles outlined in the 
Declaration of Helsinki for research involving human subjects and all participants gave written 
informed consent prior to their participation. 
Subjects were invited to the study examination center for an extensive ophthalmologic screening 
examination. In an effort to increase participation rate and to minimize potential no-participation bias, a 
home visit eye examination was arranged for persons unable to visit the study examination center 
because of illness or major disability. 
Visual acuity was measured with the Early Treatment of Diabetic Retinopathy Study (ETDRS) charts, 
and screening visual field (VF) examination (Humphrey Automated Field Analyzer II, Carl Zeiss 
Meditech, Dublin, CA) was performed for all participants with visual acuity of more than counting 
fingers. If the screening test was abnormal, a Full Threshold or Sita-Standard VF was performed. 
Intraocular pressure (IOP) was measured using a calibrated Goldmann applanation tonometer (Haag-
Streit, Bern, Switzerland). Blood pressure (BP) was measured with an automated sphygmomanometer 
(model 705CP; OMRON Matsusaka Co Ltd, Matsusaka City, Japan) before instillation of mydriatic 
drops and after the participant was seated for 10 minutes. Somatometric data (height, weight) were 
also measured.   
If the anterior chamber angle was open, dilation drops (5% phenylephrine and 0.5% tropicamide) were 
instilled. If the angle was potentially occludable, evaluation of the lens and fundus were performed 
without dilation, the participants were referred for laser peripheral iridotomy and dilated lens and 
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fundus examination was completed afterwards. The presence of pseudoexfoliative material in the 
anterior chamber of the eye was also recorded. Fundus photos of the macula and disc (Topcon, 
Japan), optic disc imaging with the Heidelberg Retina Tomograph (HRT) and Heidelberg Retinal 
Flowmeter (HRF) images (Heidelberg Engineering, Heidelberg, Germany) were acquired. Finally, 
central corneal thickness (CCT) was measured using ultrasound pachymetry (A-scan, Quantel 
Medical, France) in a subset of subjects.  
 
Tromsø Eye Study 
Tromsø Eye Study (TES) is a substudy of the multipurpose Tromsø Study, a longitudinal population-
based study started in 1974. The Tromsø Study and the cohort profile have been described elsewhere 
19
. A description of the large amount of variables collected is presented at 
http://tromsoundersokelsen.uit.no/tromso/  Blood samples from each survey and DNA samples from 
the 3rd survey and onwards are stored in a biobank. The population is being followed up with 
registration of incident myocardial infarction, stroke, atrial fibrillation, venous thromboembolism, 
diabetes and non-vertebral fractures. The study sample for the Tromsø Study is based upon the 
official population registry and all subjects were residents of the municipality of Tromsø. 
Ophthalmological data have been collected from the 5
th
 Tromsø Study survey and onwards. Details on 





 survey (2007-2008) consisted of two separate visits. The first visit included a questionnaire 
and physical examination comprising the measurement of blood pressure, height, weight and waist-to-
hip ratio. Blood sampling, bone mineral density and pain threshold tests were also performed. A total 
of 12984 subjects (65.7% attendance rate), 30-87 years participated. Among the participants attending 
the first visit, 7958 participants were invited to the 2
nd
 visit and 7307 participants (30-87 years) 
attended (91.8% attendance rate). Eye examinations were performed at the 2
nd
  visit including 
ophthalmological history, five fields 45° color retinal photographs, spectral domain optical coherence 
tomography, visual acuity and refraction. In addition the 2
nd
 visit comprised a second questionnaire, 
blood samples, cognitive tests, ultrasound of the carotid artery, 12-lead electrocardiogram, 
echocardiography, spirometry, and bone mineral densitometry.  All images were graded for diabetic 
retinopathy and retinal vessel calibers were estimated using IVAN software. Optical coherence 
tomography scans were graded for retinal thickness. AMD was graded in participants 65 years and 
older according to the International Classification. The 7th survey started 2015 and aim to include all 
participants from the 6
th
 survey and an additional random selection of residents 40 years and older. 
Data collected includes all variables from the 6
th
 survey supplemented with intraocular pressure 
measurements.     
The Tromsø Study and TES followed the tenets of the Declaration of Helsinki for research involving 
humans and were approved by the Regional Committee for Medical and Health Research Ethics. All 
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